271 related articles for article (PubMed ID: 31489804)
1. Potential value of autoantibodies as biomarkers of chronic graft-versus-host disease after allogeneic stem cell transplantation.
Hao B; Gao S; Sang YW; Wang L; Meng XQ; You JY
J Zhejiang Univ Sci B; 2019 Oct.; 20(10):849-860. PubMed ID: 31489804
[TBL] [Abstract][Full Text] [Related]
2. Anti-Ro52 Autoantibodies Are Related to Chronic Graft-vs.-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Yang K; Chen Y; Qi H; Ye Y; Fan Z; Huang F; Zhang H; Suo Y; Liu Q; Jin H
Front Immunol; 2020; 11():1505. PubMed ID: 32849514
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of autoantibody expression in allogeneic stem-cell recipients.
Moon JH; Lee SJ; Kim JG; Chae YS; Kim SN; Kang BW; Suh JS; Lee KS; Sohn SK
Transplantation; 2009 Jul; 88(2):242-50. PubMed ID: 19623021
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of autoantibodies in chronic graft vs. host disease after allogeneic stem cell transplantation.
Wechalekar A; Cranfield T; Sinclair D; Ganzckowski M
Clin Lab Haematol; 2005 Aug; 27(4):247-9. PubMed ID: 16048492
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.
Kuzmina Z; Gounden V; Curtis L; Avila D; Rnp TT; Baruffaldi J; Cowen EW; Naik HB; Hasni SA; Mays JW; Mitchell S; Baird K; Steinberg SM; Pavletic SZ
Am J Hematol; 2015 Feb; 90(2):114-9. PubMed ID: 25363867
[TBL] [Abstract][Full Text] [Related]
6. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
[TBL] [Abstract][Full Text] [Related]
8. Value of Autoantibody Expression During Long-Term Follow-Up in Paediatric ALL Patients After Allogeneic Haematopoietic Stem Cell Transplantation.
Lawitschka A; Ronceray L; Bauer D; Rittenschober M; Zubarovskaya N; Geyeregger R; Pickl WF; Kuzmina Z
Front Pediatr; 2021; 9():788360. PubMed ID: 34993166
[No Abstract] [Full Text] [Related]
9. Pentraxin-3 levels in graft-versus-host disease during allogeneic hematopoietic stem cell transplantation.
Doehn JM; Winkler A; Kuzmina Z; Hladik A; Greinix H; Knapp S; Robak O
Exp Hematol; 2016 Oct; 44(10):917-23. PubMed ID: 27403536
[TBL] [Abstract][Full Text] [Related]
10. [The clinical characteristics of polyserositis as main presentation of chronic graft-versus-host rejection disease after allogeneic hematopoietic stem cell transplantation].
Wang Q; Li Y; Qiu Z; Xu W; Sun Y; Wang L; Wang M; Liu W; Dong Y; Ou J; Wang W; Liang Z; Wang Q; Cen X; Ren H
Zhonghua Nei Ke Za Zhi; 2014 May; 53(5):394-7. PubMed ID: 25146408
[TBL] [Abstract][Full Text] [Related]
11. National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen.
Saillard C; Crocchiolo R; Furst S; El-Cheikh J; Castagna L; Signori A; Oudin C; Faucher C; Lemarie C; Chabannon C; Granata A; Blaise D
Leuk Lymphoma; 2014 May; 55(5):1106-12. PubMed ID: 23822538
[TBL] [Abstract][Full Text] [Related]
12. [Association of the ratio of regulatory and effector T cells with recurrence and chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
Wang HT; Zhao XY; Zhao XS; Han TT; Lv M; Chang YJ; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):679-84. PubMed ID: 23978019
[TBL] [Abstract][Full Text] [Related]
13. National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.
Lawitschka A; Gueclue ED; Januszko A; Körmöczi U; Rottal A; Fritsch G; Bauer D; Peters C; Greinix HT; Pickl WF; Kuzmina Z
Front Immunol; 2019; 10():1879. PubMed ID: 31507582
[TBL] [Abstract][Full Text] [Related]
14. Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.
Bohmann EM; Fehn U; Holler B; Weber D; Holler E; Herr W; Hoffmann P; Edinger M; Wolff D
Ann Hematol; 2017 Feb; 96(2):299-310. PubMed ID: 27942862
[TBL] [Abstract][Full Text] [Related]
15. CXCL9 Predicts Severity at the Onset of Chronic Graft-versus-host Disease.
Giesen N; Schwarzbich MA; Dischinger K; Becker N; Hummel M; Benner A; Radujkovic A; Müller-Tidow C; Dreger P; Luft T
Transplantation; 2020 Nov; 104(11):2354-2359. PubMed ID: 31929430
[TBL] [Abstract][Full Text] [Related]
16. The predictive value of serum free light chain level early after allogeneic hematopoietic stem cell transplantation for chronic graft-versus-host disease, a preliminary study.
Wang B; Liang Z; Liu W; Sun Y; Cen X; Dong Y; Ren H
Clin Transplant; 2020 Jul; 34(7):e13865. PubMed ID: 32242991
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Martin SJ; Audrain MA; Oksman F; Ecoiffier M; Attal M; Milpied N; Esnault VL
Bone Marrow Transplant; 1997 Jul; 20(1):45-8. PubMed ID: 9232255
[TBL] [Abstract][Full Text] [Related]
18. The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation.
Weissinger EM; Human C; Metzger J; Hambach L; Wolf D; Greinix HT; Dickinson AM; Mullen W; Jonigk D; Kuzmina Z; Kreipe H; Schweier P; Böhm O; Türüchanow I; Ihlenburg-Schwarz D; Raad J; Durban A; Schiemann M; Könecke C; Diedrich H; Holler E; Beutel G; Krauter J; Ganser A; Stadler M
Leukemia; 2017 Mar; 31(3):654-662. PubMed ID: 27677743
[TBL] [Abstract][Full Text] [Related]
19. [The clinical observation of serum specific biomarkers in patients with chronic graft-versus-host disease].
Chen T; Li XP; Zhang C; Kong PY; Gao QG; Tang L; Wang R; Yang SJ; Gao L; Liu Y; Gao L; Feng YM; Rao J; Peng XG; Zhang X
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):948-952. PubMed ID: 31856446
[No Abstract] [Full Text] [Related]
20. Association between serum high-molecular-weight adiponectin level and the severity of chronic graft-versus-host disease in allogeneic stem cell transplantation recipients.
Nakasone H; Binh PN; Yamazaki R; Tanaka Y; Sakamoto K; Ashizawa M; Sato M; Terasako K; Kimura S; Kikuchi M; Kako S; Okuda S; Oshima K; Tanihara A; Nishida J; Abe Y; Kanda Y
Blood; 2011 Mar; 117(12):3469-72. PubMed ID: 21258011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
